| Code Type | Code | Effective* |
| Testing (CDC) | U0001 | 2/4/2020 |
| Testing (Non-CDC) | U0002 | 2/4/2020 |
| Testing (Industry Standard) | 87635 | 3/13/2020 |
| Testing (Infectious Disease) | 0202U | 5/20/2020 |
| Testing (Throughput) | U0003 | 4/14/2020 |
| Testing (Throughput) | U0004 | 4/14/2020 |
| Testing (Antigen) | 0223U | 6/25/2020 |
| Testing (Antigen) | 0224U | 6/25/2020 |
| Testing (Infectious Disease) | 0225U | 8/10/2020 |
| Testing (sVNT) | 0226U | 8/10/2020 |
| Testing | 86413 | 9/8/2020 |
| Testing (Infectious Disease) | 0240U | 10/6/2020 |
| Testing (Infectious Disease) | 0241U | 10/6/2020 |
| Testing (Infectious Agent Detection) | 87636 | 10/6/2020 |
| Testing (Infectious Agent Detection) | 87637 | 10/6/2020 |
| Testing (Infectious Agent Detection) | 87811 | 10/6/2020 |
| Mutation identification SARS CoV-2 | 87913 | 2/21/2022 |
| Testing (Add-On Payment) | U0005 | 1/1/2021 |
| OTC At Home COVID Tests | N/A | 1/15/2022 |
| Screening | Z03.818 | 2/4/2020 |
| Screening (Specimen Transfer) | G2023 | 3/1/2020 |
| Screening (Specimen Transfer) | G2024 | 3/1/2020 |
| Screening (Specimen Transfer) | C9803 | 3/1/2020 |
| Screening (Antibody Testing) | 86328 | 4/10/2020 |
| Screening (Antibody Testing) | 86769 | 4/10/2020 |
| Screening (Antigen Detection) | 87426 | 6/25/2020 |
| Screening (Antigen Detection) | 87428 | 11/10/2020 |
| Screening (Neutralizing Antibody) | 86408 | 8/10/2020 |
| Screening (Neutralizing Antibody) | 86409 | 8/10/2020 |
| Encounter for Screening COVID-19 | Z11.52 | 1/1/2021 |
| Contact with and (suspected) exposure to COVID-19 | Z20.822 | 1/1/2021 |
| VEKLURY Antiviral Medication | J0248 | 12/23/2021 |
| Convalescent Plasma | C9507 | 12/28/2021 |
| Multisystem inflammatory syndrome (MIS) | M35.81 | 1/1/2021 |
| Treatment | U07.1 | 4/1/2020 |
| Treatment | B97.29 | 1/27/2020-3/31/2020 |
| AstraZeneca – Tixagev and Cilgav Injection | Q0220 | 12/8/2021 |
| AstraZeneca – Tixagev and Cilgav Injection | M0220 | 12/8/2021 |
| AstraZeneca – Tixagev and Cilgav Injection | M0221 | 12/8/2021 |
| AstraZeneca – Tixagev and Cilgav Injection | Q0221 | 2/24/2022 |
| Eli Lily – Bebtelovimab Injection | Q0222 | 2/11/2022 |
| Eli Lily – Bebtelovimab Injection | M0222 | 2/11/2022 |
| Eli Lily – Bebtelovimab Injection | M0223 | 2/11/2022 |
| Eli Lily Monoclonal - Bamlan/Etesev Injection | Q0245 | 2/9/2021 |
| Eli Lily Monoclonal - Bamlan/Etesev Infusion | M0245* | 2/9/2021 |
| Eli Lily Monoclonal - Bamlan/Etesev Infusion | M0246 | 5/6/2021 |
| GSK Monoclonal - Sotrov Injection | Q0247 | 5/26/2021 |
| GSK Monoclonal - Sotrov Infusion | M0247* | 5/26/2021 |
| GSK Monoclonal - Sotrov Infusion In Home | M0248 | 5/26/2021 |
| Genentech Monoclonal - Tocili Injection | Q0249 | 6/24/2021 |
| Genentech Monoclonal - Tocili 1st Infusion | M0249* | 6/24/2021 |
| Genentech Monoclonal - Tocili 2nd Infusion | M0250* | 6/24/2021 |
| Eli Lily Monoclonal - Bamlan Injection | Q0239 | 11/10/2020 - 5/6/21 |
| Eli Lily Monoclonal - Bamlan Infusion | M0239* | 11/10/2020 - 5/6/21 |
| Regeneron Monoclonal - Casiri/Imdev Injection | Q0243 | 11/21/2020-1/23/22 |
| Regeneron Monoclonal - Casiri/Imdev Infusion | M0243* | 11/21/2020-1/23/22 |
| Regeneron Monoclonal - Casiri/Imdev Injection | Q0244 | 6/3/2021-1/23/22 |
| Regeneron Monoclonal - Casiri/Imdev Infusion | M0244 | 5/6/2021-1/23/22 |
| Regeneron Monoclonal - Casiri/Imdev Injection | Q0240 | 7/30/2021-1/23/22 |
| Regeneron Monoclonal - Casiri/Imdev Infusion | M0240 | 7/30/2021-1/23/22 |
| Regeneron Monoclonal - Casiri/Imdev Infusion | M0241 | 7/30/2021-1/23/22 |
| Home Vaccine Admin | M0201 | 6/8/2021 |
| Pfizer Vaccine | 91300 | 12/11/2020 |
| Pfizer Vaccine Admin - 1st Dose | 0001A | 12/11/2020 |
| Pfizer Vaccine Admin - 2nd Dose | 0002A | 12/11/2020 |
| Pfizer Vaccine Admin - 3rd Dose | 0003A | 8/12/2021 |
| Pfizer Vaccine Admin - Booster | 0004A | 9/22/2021 |
| Moderna Vaccine | 91301 | 12/18/2020 |
| Moderna Vaccine Admin - 1st Dose | 0011A | 12/18/2020 |
| Moderna Vaccine Admin - 2nd Dose | 0012A | 12/18/2020 |
| Moderna Vaccine Admin - 3rd Dose | 0013A | 8/12/2021 |
| Moderna Vaccine (Low Dose) | 91306 | 10/20/2021 |
| Moderna Vaccine (Low Dose) - Booster | 0064A | 10/20/2021 |
| Janssen Vaccine | 91303 | 2/27/2021 |
| Janssen Vaccine Admin - Single Dose | 0031A | 2/27/2021 |
| Janssen Vaccine Admin – Booster | 0034A | 10/20/21 |
| Pfizer Vaccine (Pediatric) | 91307 | 10/29/2021 |
| Pfizer Vaccine (Pediatric) Admin - 1st Dose | 0071A | 10/29/2021 |
| Pfizer Vaccine (Pediatric) Admin - 2nd Dose | 0072A | 10/29/2021 |
| NEW - SARS-COV2 Vaccine, mRNA-LNP 10MCG/0.2mL for 5 - 11 years - Booster | 0074A | 5/17/2022 |
| Pfizer Vaccine (Ready to use) | 91305 | 1/3/2022 |
| Pfizer Vaccine (Ready to use) Admin - 1st Dose | 0051A | 1/3/2022 |
| Pfizer Vaccine (Ready to use) Admin - 2nd Dose | 0052A | 1/3/2022 |
| Pfizer Vaccine (Ready to use) Admin - 3rd Dose | 0053A | 1/3/2022 |
| Pfizer Vaccine (Ready to use) Admin – Booster | 0054A | 1/3/2022 |
| Administration - Moderna COVID-19 Vaccine 50MCG/0.5ML – Booster | 0094A | 3/7/2022 |
| SARS-COV2 Vaccine, mRNA-LNP 50MCG/0.5mL | 91309 | 3/7/2022 |
| Administration - SARS-COV2 Vaccine, mRNA-LNP 3MCG/0.2mL for 6 months – 5 years – 1st Dose | 0081A | 2/2/2022 |
| Administration - SARS-COV2 Vaccine, mRNA-LNP 3MCG/0.2mL for 6 months – 5 years – 2nd Dose | 0082A | 2/1/2022 |
| SARS-COV2 Vaccine, mRNA-LNP 3MCG/0.2mL for 6 months – 5 years | 91308 | 2/1/2022 |